Skip to main content

Select Drug Profiles

Conference Correspondent
Biomarkers that Predict Development or Worsening of Lupus Nephritis in Patients with Systemic Lupus Erythematosus
Read More
Conference Correspondent
Can MDHAQ/RAPID3 Be Used in Usual Care of Patients with Systemic Lupus Erythematosus?
Read More
Conference Correspondent
Exploring a Novel Therapeutic Target in a Murine Model of Systemic Lupus Erythematosus: Targeting Sphingosine-1-Phosphate Receptors
Read More
Conference Correspondent
Serious Infections among Patients with Lupus Who Receive Corticosteroids and Immunosuppressants
Read More
Conference Correspondent
Adding Abatacept to the Euro-Lupus Nepthritis Regimen in Patients with Lupus Nephritis: Results from ACCESS, a 24-Week, Double-Blind Controlled Trial
Read More
Conference Correspondent
Association of Psoriasis and Psoriatic Arthritis with Lupus
Read More
Perspectives
“Pharma Value”
David B. Nash, MD, MBA
Read More
Perspectives
Fall Follies: The ACA Lurches into Operation
Joseph R. Antos, PhD
Read More
Practice Management
Development of a Medicare Beneficiary Comprehension Test: Assessing Medicare Part D Beneficiaries’ Comprehension of Their Benefits
Meghana Aruru, PhD, MBA, BSPharm, J. Warren Salmon, PhD
Stakeholder Perspective
Understanding the Options: An Essential Ingredient in Our Evolving Healthcare System
by Joseph R. Antos, PhD
Read More
Practice Management
The Economics of Biosimilars
Erwin A. Blackstone, PhD, Joseph P. Fuhr, Jr, PhD
Stakeholder Perspective
Modeling the Future Economic Impact of Biosimilars’ Entry into the US Market
by Grant D. Lawless, RPh, MD, FACP
Read More
Page 164 of 244
Results 1631 - 1640 of 2438